EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Generation and characterization of a novel MHC-II tetramer for tracking and characterization of toxin B–specific CD4+ T cell responses

Jeffrey R Maslanka iD, Qianxuan She, Kathleen S Krauss, Emily N Bitsko, Nile U Bayard, Jennifer A Londregan, Mohamad-Gabriel Alameh, Laurence C Eisenlohr, Michele A Kutzler, Joseph P Zackular iD, Michael C Abt iD

The Journal of Immunology · 04.08.2026 · 215 (8)

DOI: 10.1093/jimmun/vkag152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 14.08.2026. Verfasst von Jeffrey R Maslanka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Bacterial Toxins, Bacterial Proteins, Histocompatibility Antigens Class II. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health/National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gastrointestinal pathogen Clostridioides difficile is a major burden for health systems due to high rates of recurrence. C. difficile pathogenesis is mediated by two virulence factors, toxin A (TcdA) and toxin B (TcdB). Antibodies specific for TcdA and TcdB are correlated with protection from symptomatic recurrence; however, the role for CD4+ T cells is poorly understood in part due to the lack of tools to study the toxin-specific CD4+ T cell response. Our group recently demonstrated the antibody and CD4+ T cell response to C. difficile toxins is impaired via the glucosyltransferase activity of the toxins; however, tools do not exist to study the protective capacity and the phenotype of toxin-specific CD4+ T cells. Therefore, we developed a major histocompatibility complex class II (MHC-II) tetramer to identify TcdB-specific CD4+ T cells via flow cytometry. Herein, we identified an immunodominant epitope (TcdB1961–1975) in the CROPs region of TcdB and optimized an MHC-II tetramer for use in tracking and phenotyping TcdB-specific CD4+ T cell responses following multiple different immunization strategies in mice. Utilizing the tetramer, TcdB-specific T follicular helper cells were detected following TcdB-CROPs messenger RNA lipid nanoparticle vaccination validating the advantage of the tetramer. Furthermore, using a modular messenger RNA vector expressing the TcdB1961 peptide covalently bound to the beta chain of MHC-II, we were able to generate a robust population of TcdB-specific CD4+ T cells. These data outline the generation of new tools for the C. difficile field and lay the groundwork for future studies of toxin-specific CD4+ T cell responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD4-Positive T-LymphocytesBacterial ToxinsBacterial ProteinsHistocompatibility Antigens Class IIClostridioides difficileClostridium InfectionsAnimalsMiceEnterotoxinsEpitopes, T-LymphocyteMice, Inbred C57BLImmunodominant Epitopes

Stichwörter der Autor:innen

C. difficileCD4+ T cell epitopesmRNA-LNPtetramertoxin B

Substanzen

Bacterial ToxinsBacterial ProteinstoxB protein, Clostridium difficileHistocompatibility Antigens Class IIEnterotoxinsEpitopes, T-LymphocyteImmunodominant Epitopes

Autor:innen und Institutionen

  • Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Immunology Graduate Group, University of Pennsylvania, Philadelphia, PA, United States.
  • Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Center for Microbial Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Department of Medicine, Drexel University College of Medicine, Philadelphia, PA, United States.
  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

ORCID-Profile: Jeffrey R Maslanka, Joseph P Zackular, Michael C Abt

Förderung

  • National Institutes of Health/National Institute of Allergy and Infectious Diseases

Zitieren

APA

Maslanka, J. R., She, Q., Krauss, K. S., Bitsko, E. N., Bayard, N. U., Londregan, J. A., Alameh, M. G., Eisenlohr, L. C., Kutzler, M. A., Zackular, J. P., & Abt, M. C. (2026). Generation and characterization of a novel MHC-II tetramer for tracking and characterization of toxin B–specific CD4+ T cell responses. The Journal of Immunology, 215(8). https://doi.org/10.1093/jimmun/vkag152

Vancouver

Maslanka JR, She Q, Krauss KS, Bitsko EN, Bayard NU, Londregan JA, et al. Generation and characterization of a novel MHC-II tetramer for tracking and characterization of toxin B–specific CD4+ T cell responses. The Journal of Immunology. 2026;215(8). doi:10.1093/jimmun/vkag152

BibTeX
@article{Maslanka2026,
  author = {Maslanka, Jeffrey R and She, Qianxuan and Krauss, Kathleen S and Bitsko, Emily N and Bayard, Nile U and Londregan, Jennifer A and Alameh, Mohamad-Gabriel and Eisenlohr, Laurence C and Kutzler, Michele A and Zackular, Joseph P and Abt, Michael C},
  title = {Generation and characterization of a novel MHC-II tetramer for tracking and characterization of toxin B–specific CD4+ T cell responses},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {8},
  doi = {10.1093/jimmun/vkag152}
}
Kostenlos starten →